P53 Cancer Research Results

P53, P53-Guardian of the Genome: Click to Expand ⟱
Source: TCGA
Type: Proapototic
TP53 is the most commonly mutated gene in human cancer. TP53 is a gene that encodes for the p53 tumor suppressor protein ; TP73 (Chr.1p36.33) and TP63 (Chr.3q28) genes that encode transcription factors p73 and p63, respectively, are TP53 homologous structures.
p53 is a crucial tumor suppressor protein that plays a significant role in regulating the cell cycle, maintaining genomic stability, and preventing tumor formation. It is often referred to as the "guardian of the genome" due to its role in protecting cells from DNA damage and stress.
TP53 gene, which encodes the p53 protein, is one of the most frequently mutated genes in human cancers.
Overexpression of MDM2, an inhibitor of p53, can lead to decreased p53 activity even in the presence of wild-type p53.
In some cancers, particularly those with mutant p53, there may be an overexpression of the p53 protein.
Cancers with overexpression: Breast, lung, colorectal, overian, head and neck, Esophageal, bladder, pancreatic, and liver.


Scientific Papers found: Click to Expand⟱
2832- FIS,    Fisetin's Promising Antitumor Effects: Uncovering Mechanisms and Targeting for Future Therapies
- Review, Var, NA
MMP↓, mtDam↑, Cyt‑c↑, Diablo↑, Casp↑, cl‑PARP↑, Bak↑, BIM↑, Bcl-xL↓, Bcl-2↓, P53↑, ROS↑, AMPK↑, Casp9↑, Casp3↑, BID↑, AIF↑, Akt↓, mTOR↓, MAPK↓, Wnt↓, β-catenin/ZEB1↓, TumCCA↑, P21↑, p27/CDKN1B↑, cycD1/CCND1↓, cycE/CCNE↓, CDK2↓, CDK4↓, CDK6↓, TumMeta↓, uPA↓, E-cadherin↑, Vim↓, EMT↓, Twist↓, DNAdam↑, ROS↓, COX2/PTGS2↓, PGE2↓, HSF1↓, cFos↓, cJun↓, AP-1↓, Mcl-1↓, NF-kB↓, IRE1↑, ER Stress↑, ATF4↑, GRP78/BiP↑, MMP2↓, MMP9↓, TCF-4↓, MMP7↓, RadioS↑, TOP1↓, TOP2↓,
6980- Form,    The potential role of formononetin in cancer treatment: An updated review
- Review, Var, NA
TumCP↓, TumCI↓, TumMeta↓, Apoptosis↑, TumCCA↑, p‑Akt↑, p38↑, P21↑, P53↑, NF-kB↓, ERK↓, LAMs↓, JAK↓, STAT↓, Akt↓,
6981- Form,    Formononetin: a review of its source, pharmacology, drug combination, toxicity, derivatives, and drug delivery systems
- Review, Var, NA - Review, AD, NA - Review, PSA, NA
BioAv↝, *memory↑, *ROS↓, *AChE↓, *NF-kB↓, *Keap1↝, *NRF2↑, *Inflam↓, *PGC-1α↝, *HO-1↓, *p‑tau↓, *cognitive↑, *BDNF↑, *5HT↑, *Stroke↓, *PARP1↓, *AIF↓, *Casp3↓, NP/CIPN↓, *neuroP↑, *NGF↑, *TNF-α↓, *IL1β↓, *IL18↓, *IL6↓, *VCAM-1↓, *pol-M2 MC↑, *hepatoP↑, *AST↓, *ALAT↓, *LC3II↑, *Beclin-1/ATG6↑, *p62↑, *COX2/PTGS2↑, *MMP↑, *ATP↑, *GSH↑, *Catalase↑, *GPx↑, *MDA↓, *antiPs↑, *AntiDiabetic↑, *glucose↓, *Insulin↑, *GutMicro↑, *Obesity↓, COX2/PTGS2↓, cycD1/CCND1↓, TumCCA↑, EGFR↓, GSK‐3β↑, Mcl-1↓, *toxicity↓, TumCP↓, Hif1a↓, VEGF↓, ERK↓, LAMs↓, Cyt‑c↑, Casp9↑, Casp3↑, PARP↑, TumCD↑, mitA↑, BACH1↓, P53↓, ROS↑, PD-1↓, NF-kB↓, *Bacteria↓, *AntiViral↑, *mt-ROS?, *PI3K↓, *chemoP↑, ChemoSen↑, Synergy↑, *toxicity↓, *BioAv↑, *BioAv↑, *Synergy↑, *antiAll↑,
6976- Form,    Study on the Mechanism of Formononetin Against Hepatocellular Carcinoma: Regulating Metabolic Pathways of Ferroptosis and Cell Cycle
- vitro+vivo, HCC, HepG2
ROS↑, DNAdam↑, TumCCA↑, CHK1↝, CDC25↝, CDK1↝, CycB/CCNB1↝, GSH↓, lipid-P↑, Ferroptosis↑, xCT/SLC7A11↓, P53↓, GPx4↓, other↝, TumCP↓, γH2AX↑, TumCG↓, Ki-67↓, PCNA↓, MMP↓,
8308- FS,  lign,    The treatment effects of flaxseed-derived secoisolariciresinol diglycoside and its metabolite enterolactone on benign prostatic hyperplasia involve the G protein-coupled estrogen receptor 1
- in-vivo, BPH, NA
*eff↑, *other↝, *GPER↑, *TumCCA↑, *P53↑, *P21↑, *cycD1/CCND1↓,
8584- FS,    Anti-Oxidant and Anti-Cancer Properties of Flaxseed
- Review, Nor, NA
*Ingr↝, *cardioP↑, *LDL↓, *lipidLev↓, *AntiDiabetic↑, *hepatoP↑, *AntiCan↑, *Analgesic↑, *AntiArt↑, *CRP↓, *TNF-α↓, *Inflam↓, *toxicity↝, *neuroP↑, *Ingr↝, *Ingr↝, *AntiViral↑, Risk↓, *Ingr↝, *hs-CRP↓, *GutMicro↑, *TJ↑, *OCLN↝, *MLC2/MYL9↝, *VCAM-1↓, *Akt2↓, *IKKα↓, *NF-kB↓, Synergy↑, HER2/EBBR2↓, MAPK↓, PI3K↓, Akt↓, EGFR↓, TumCG↓, TumMeta↓, IGF-1↓, COX2/PTGS2↓, PGE2↓, CDK4↓, TNF-α↓, IL1β↓, lipid-P↑, P53↑, MDM2↑, cl‑Casp3↑, cl‑PARP↑, cl‑Casp7↑, BAX↑, Bcl-2↓, Bax:Bcl2↑, Cyt‑c↑, Casp9↑, Ki-67↓, CYP1A1↑, p38↑, ERK↑, Synergy↑, ChemoSen↑, *BioAv↑, eff↝, Ingr↝,
8589- FS,    Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets
- Study, Var, NA
Risk↓, Ingr?, *antiOx?, *Inflam↓, *Estro↓, *Ingr↑, *neuroP↑, *Obesity↓, TumMeta↓, TumCP↓, *AntiAg↑, *AntiDiabetic↑, *ROS↓, *GutMicro↑, FOXM1↓, PCNA↓, Ki-67↓, CDK2↓, Akt↓, PDGF↓, ERK↓, p‑GSK‐3β↓, IGFR↓, p‑MDM2↓, EGFR↓, FASN↓, CYP3A4↓, COX2/PTGS2↓, Cyt‑c↑, cl‑PARP↑, Casp3↑, p‑P53↑, Bcl-2↓, VEGF↓, VEGFR2/KDR/Flk1↓, BRCA1↓, BRCA2↓, survivin↓, GADD45A↓, FAK↓, pax↓, Rho↓, Rac1↓, Cdc42↓, MMP2↓, TIMP1↑, TIMP2↑, angioG↓, MMP↓, ChemoSen↑,
8608- FSO,  Cisplatin,    Flax seed oil reduced tumor growth, modulated immune responses and decreased HPV E6 and E7 oncoprotein expression in a murine model of ectopic cervical cancer
- in-vivo, Cerv, NA
TumVol↓, TumW↓, ChemoSen↑, *TAC↑, lipid-P↑, CD8+↑, IFN-γ↑, IL4↓, E6↓, E7↓, P53↑,
1300- GA,  PacT,  carbop,    Gallic acid potentiates the apoptotic effect of paclitaxel and carboplatin via overexpression of Bax and P53 on the MCF-7 human breast cancer cell line
- in-vitro, BC, MCF7
TumCCA↑, Apoptosis↑, P53↑, BAX↑, Casp3↑, Bcl-2↓,
7048- GA,    Natural bioactive gallic acid shows potential anticancer effects by inhibiting the proliferation and invasiveness behavior in human embryonic carcinoma cells
- in-vitro, Var, NA
AntiCan↑, TumCCA↑, angioG↓, TumCMig↓, TumMeta↓, CSCs↓, Apoptosis↑, P21↑, P53↑, p27/CDKN1B↑, CDK4↓, cycE/CCNE↓, cycD1/CCND1↓, SOX2↓, Nanog↓, OCT4↓, ROS↑, DNAdam↑, BRCA1↑, ATM↑, CHK1↑, Chk2↑, Histones↑, TumCI↓, MMPs↓, EGFR↓, JAK2↓, STAT5↓,
7033- GA,  OL,    Gallic Acid Enhances Olaparib-Induced Cell Death and Attenuates Olaparib Resistance in Human Osteosarcoma U2OS Cell Line
- in-vitro, OS, U2OS
tumCV↓, angioG↓, DNAdam↑, Apoptosis↑, cl‑PARP↓, Bcl-2↓, BAX↑, ROS↓, Synergy↑, TumCMig↓, VEGF↓, Casp9↑, P53↑, selectivity↑,
997- GA,    The Inhibitory Mechanisms of Tumor PD-L1 Expression by Natural Bioactive Gallic Acid in Non-Small-Cell Lung Cancer (NSCLC) Cells
- in-vitro, Lung, A549 - in-vitro, Lung, H292 - in-vitro, Nor, HUVECs
PD-L1↓, p‑EGFR↓, p‑PI3K↓, p‑Akt↓, P53↑, miR-34a↑, *toxicity↓,
5152- GamB,    Gambogic Acid as a Candidate for Cancer Therapy: A Review
- Review, Var, NA
AntiCan↑, Apoptosis↑, TumAuto↑, TumCCA↑, TumCI↓, TumMeta↓, angioG↓, eff↑, NF-kB↓, P53↑, P21↑, MDM2↓, HSP90↓, Bcl-2↓, Cyt‑c↑, Casp↑, MMP↓, Casp3↑, Casp9↑, cl‑PARP↑, Bax:Bcl2↑, ROS↑, SIRT1↓, TrxR1↓, Fas↓, FasL↑, FADD↑, APAF1↑, DNAdam↑, NF-kB↓, STAT3↓, MAPK↓, cFos↓, EGFR↓, Akt↓, mTOR↓, AMPK↑, TumCCA↑, ChemoSen↑, P-gp/ABCB1↓, survivin↓,
5148- GamB,    Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics
- Review, Var, NA
AntiCan↑, angioG↓, ChemoSen↑, RadioS↑, VEGF↓, MMP2↓, MMP9↓, Telomerase↓, TrxR↓, ERK↓, HSP90↓, ROS↑, SIRT1↑, survivin↓, cFLIP↓, Casp3↑, Casp8↑, Casp9↑, BAD↓, BID↓, Bcl-2↓, BAX↑, STAT3↓, hTERT/TERT↓, NF-kB↓, Myc↓, Hif1a↓, FOXD3↑, BioAv↓, BioAv↑, P53↑, eff↓, OCR↓, MMP↓, PI3K↓, Akt↓, BBB↑, TumCG↓, TumMeta↓, BioAv↑,
1959- GamB,    Gambogic acid induces GSDME dependent pyroptotic signaling pathway via ROS/P53/Mitochondria/Caspase-3 in ovarian cancer cells
- in-vitro, Ovarian, NA - in-vivo, NA, NA
AntiCan↑, Pyro↑, tumCV?, CellMemb↓, cl‑Casp3↑, GSDME-N↑, ROS?, p‑P53↑, eff↓, MMP↓, Bcl-2↓, BAX↑, mtDam↑, Cyt‑c↑, TumCG↓, CD4+↑, CD8+↑,
7063- GamB,    Gambogic acid mediates apoptosis as a p53 inducer through down-regulation of mdm2 in wild-type p53-expressing cancer cells
- vitro+vivo, Lung, H1299
TumCG↓, P53↑, MDM2↓, Apoptosis↑,
7060- GamB,    New targets for the antitumor activity of gambogic acid in hematologic malignancies
- Review, Melanoma, RPMI-8226
AntiCan↑, TumCP↓, Apoptosis↑, SRC3↓, DIDO1/DIO-1↑, KCNH2/hERG↓, ROS↑, Bcl-2↓, P53↑, cMyc↓, VEGF↓, Casp3↑, cl‑PARP1↑, eff↓,
7059- GamB,    Gambogic acid inhibits growth, induces apoptosis, and overcomes drug resistance in human colorectal cancer cells
- in-vitro, CRC, HCT15
TumCP↓, Apoptosis↑, JNK↑, TumCCA↑, cycD1/CCND1↓, P53↑, Casp3↑, Casp8↑, Casp9↑, cl‑PARP↑, MMP↓, Cyt‑c↑, Bcl-2↓, Bcl-xL↓, Mcl-1↓, XIAP↓, survivin↓,
7087- GAR,    Garcinol as an Epigenetic Modulator: Mechanisms of Anti-Cancer Activity and Therapeutic Potential
- Review, Var, NA
HATs↓, p300↓, CBP↓, NF-kB↓, STAT3↓, PI3K↓, Akt↓, MAPK↓, Wnt↓, β-catenin/ZEB1↓, Inflam↓, angioG↓, TumCP↓, TumMeta↓, TumCCA↑, EMT↓, CSCs↓, P53↑, TrxR↓, ROS↑, JNK↑, DNAdam↑, mt-Apoptosis↑, ER Stress↑, CHOP/DDIT3↑, DDIT4↑, TRIB3↑, SESN2↑, miR-218↑, eff↑, ChemoSen↑, BioAv↓, Half-Life↓, BioAv↑,
804- GAR,    Garcinol inhibits the proliferation of endometrial cancer cells by inducing cell cycle arrest
- in-vitro, EC, HEC1B - in-vitro, EC, ISH
TumCP↓, TumCCA↑, P53↑, P21↑, CDK2↓, CDK4↓, cycD1/CCND1↓, CycB/CCNB1↓, p‑cJun↑,
7211- GBE,    Ginkgo Biflavones Cause p53 Wild-Type Dependent Cell Death in a Transcription-Independent Manner of p53
- in-vitro, CRC, HCT116
P53↑, MDM2↓, TumCD↓, tumCV↓, Apoptosis↑, TumCCA↑, ROS↑, Ferroptosis↑, ChemoSen↑,
7102- GEN,    Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits
- Review, Var, NA
*antiOx↑, *Inflam↓, *Bacteria↓, *AntiViral↑, *Dose↝, *AntiDiabetic↑, angioG↑, Apoptosis↑, tumCV↓, MyD88↑, Beclin-1/ATG6↑, LC3II↑, TLR4↑, TumAuto↑, mTOR↓, p62↓, TumCCA↑, TumCP↓, Akt↑, P53↑, DNMT3B↓, MEK↓, hTERT/TERT↓, VEGF↓, NF-kB↓, IAP1↓, MDR1↓, p‑Akt↓, Synergy↑, ChemoSen↑,
6562- Ger,    Potential Effects of Geraniol on Cancer and Inflammation-Related Diseases: A Review of the Recent Research Findings
- Review, Var, NA - Review, AD, NA
*Inflam↓, *AntiCan↑, *AntiBio↑, *antiOx↑, *neuroP↑, ROS↓, Apoptosis↑, TumCCA↑, P53↝, STAT3↓, Casp↝, *Catalase↑, *GSTs↑, *GPx↑, *AChE↓, *GSH↑, *SOD↑, *TBARS↓, *NO↓, *XO↓, *memory↑, *IL1β↓, *iNOS↓, *NF-kB↓, *COX2/PTGS2↓, *NRF2↑, *HO-1↑, *survivin↓, TumCP↓, TumCMig↓, TumCG↑, selectivity↑, TumMeta↓, angioG↓, Hif1a↓, Beclin-1/ATG6↓, *antiAll↑,
6573- Ger,    Systematic elucidation of the mechanism of geraniol via network pharmacology
- Study, Nor, NA - Study, Var, NA
HO-1↝, HRAS↓, *IL8↓, *AChE↓, NF-kB↓, PCNA↓, BAX↑, Bcl-2↓, P53↑, Casp3↑, Casp8↑, Casp9↑,
4510- GLA,    Gamma-linolenic acid therapy of human glioma-a review of in vitro, in vivo, and clinical studies
- Review, GBM, NA
Apoptosis↑, selectivity↑, eff↓, ROS↑, lipid-P↑, P53↑, radioP↑, chemoP↑,
401- GoldNP,  MF,    In vitro evaluation of electroporated gold nanoparticles and extremely-low frequency electromagnetic field anticancer activity against Hep-2 laryngeal cancer cells
- in-vitro, Laryn, HEp2
Casp3↑, P53↑, BAX↑, Bcl-2↓,
854- Gra,  AgNPs,    Green Synthesis of Silver Nanoparticles Using Annona muricata Extract as an Inducer of Apoptosis in Cancer Cells and Inhibitor for NLRP3 Inflammasome via Enhanced Autophagy
- vitro+vivo, AML, THP1 - in-vitro, AML, AMJ13 - vitro+vivo, lymphoma, HBL
TumCP↓, TumAuto↑, IL1↓, NLRP3↓, Apoptosis↑, mtDam↑, P53↑, LDH↓,
1234- Gra,    Graviola attenuates DMBA-induced breast cancer possibly through augmenting apoptosis and antioxidant pathway and downregulating estrogen receptors
- in-vivo, BC, NA
Apoptosis↑, BAX↑, P53↑, Casp3↑, ER-α36↓, lipid-P↓,
2519- H2,    Hydrogen: an advanced and safest gas option for cancer treatment
- Review, Var, NA
antiOx↑, neuroP↓, BBB↑, toxicity∅, TumCP↓, Apoptosis↓, ROS↑, Hif1a↓, NF-kB↓, P53?, OS↑, chemoP↑,
1638- HCAs,    Anticancer potential of hydroxycinnamic acids: mechanisms, bioavailability, and therapeutic applications
- Review, Nor, NA
*BioAv↓, Inflam↓, COX2/PTGS2↓, TumCCA↑, ChemoSen↑, RadioS↑, selectivity↑, ROS↑, DNAdam↑, antiOx↑, SOD↑, Catalase↑, GPx↑, GSH↑, NRF2↑, NF-kB↓, Cyc↓, CDK1↑, P21↑, p27/CDKN1B↑, P53↑, VEGF↓, MAPK↓,
7359- HibSad,    Novel Insight into the Cellular and Molecular Signalling Pathways on Cancer Preventing Effects of Hibiscus sabdariffa: A Review - PubMed
- Review, Var, NA
AntiCan↑, TumCP↓, Apoptosis↑, TumCCA↑, P53↑, P21↑, p27/CDKN1B↑, BAD↑, BAX↑, Casp3↑, Casp7↑, Casp8↑, Casp9↑, *AntiBio↑, *Inflam↓, *antiOx↑, *BP↓, *AntiDiabetic↑, HDAC1↓, HDAC3↓, tumCV↓, LDL↓, DNAdam↑, MMP↓, *Catalase↑, *SOD↑, *GPx↑, *GSH↑, *antiOx↑, *ROS↓, TumCMig↓, TumCI↓, selectivity↑, RAS↓, Akt↓, NF-kB↓, MMP2↓, PI3K↓, Bcl-2↓, Bcl-xL↓, PCNA↓, cycA1/CCNA1↓, cycD1/CCND1↓, cycE/CCNE↓,
7365- HibSad,    Insight into the molecular evidence supporting the remarkable chemotherapeutic potential of Hibiscus sabdariffa L
- Review, Var, NA
chemoPv↑, selectivity↑, TumCCA↑, Apoptosis↑, TumAuto↑, TumMeta↓, ATG5↑, Beclin-1/ATG6↑, LC3II↑, MMP2↓, MMP9↓, CD31/PECAM-1↓, VEGF↓, uPA↓, TIMP2↑, NF-kB↓, p38↑, P53↑, Casp3↑, Casp8↑, Casp9↑, Bcl-2↓, BAX↑, Cyt‑c↑, TNF-α↑, Fas↑, FasL↑, JNK↑, cJun↑, angioG↓, VEGFR2/KDR/Flk1↓, PCNA↓, CCN2/CTGF↓, RAGE↓,
7350- HibSad,    Hibiscus polyphenol-rich extract induces apoptosis in human gastric carcinoma cells via p53 phosphorylation and p38 MAPK/FasL cascade pathway
- in-vitro, GC, AGS
TumCD↑, DNAdam↑, P53↑, Bcl-2↓, Mcl-1↓, Cyt‑c↑, FasL↑, Fas↑, p38↑, BAX↑, Dose↝, TumCCA↑,
2865- HNK,    Liposomal Honokiol induces ROS-mediated apoptosis via regulation of ERK/p38-MAPK signaling and autophagic inhibition in human medulloblastoma
- in-vitro, MB, DAOY - vitro+vivo, NA, NA
BioAv↓, BioAv↓, TumCP↓, selectivity↑, P53↑, P21↑, CDK4↓, cycD1/CCND1↓, mtDam↑, ROS↑, eff↓, Casp3↑, BAX↑, LC3II↑, Beclin-1/ATG6↑, ATG7↑, p62↑, Synergy↑, ChemoSen↑, *toxicity↓,
2864- HNK,    Honokiol: A Review of Its Anticancer Potential and Mechanisms
- Review, Var, NA
TumCCA↑, CDK2↓, EMT↓, MMPs↓, AMPK↑, TumCI↓, TumCMig↓, TumMeta↓, VEGFR2/KDR/Flk1↓, *antiOx↑, *Inflam↓, *BBB↑, *neuroP↑, *ROS↓, Dose↝, selectivity↑, Casp3↑, Casp9↑, NOTCH1↓, cycD1/CCND1↓, cMyc↓, P21?, DR5↑, cl‑PARP↑, P53↑, Mcl-1↑, p65↓, NF-kB↓, ROS↑, JNK↑, NRF2↑, cJun↑, EF-1α↓, MAPK↓, PI3K↓, mTORC1↓, CSCs↓, OCT4↓, Nanog↓, SOX4↓, STAT3↓, CDK4↓, p‑RB1↓, PGE2↓, COX2/PTGS2↓, β-catenin/ZEB1↑, IKKα↓, HDAC↓, HATs↑, H3↑, H4↑, LC3II↑, c-Raf↓, SIRT3↑, Hif1a↓, ER Stress↑, GRP78/BiP↑, cl‑CHOP/DDIT3↑, MMP↓, PCNA↓, Zeb1↓, NOTCH3↓, CD133↓, Nestin↓, ATG5↑, ATG7↑, survivin↓, ChemoSen↑, SOX2↓, OS↑, P-gp/ABCB1↓, Half-Life↓, Half-Life↝, Synergy↑, BioAv↓,
7528- HT,    Involvement of the PI3K/AKT Intracellular Signaling Pathway in the AntiCancer Activity of Hydroxytyrosol, a Polyphenol from Olea europaea, in Hematological Cells and Implication of HSP60 Levels in Its Anti-Inflammatory Activity
- in-vitro, AML, Jurkat - in-vitro, AML, HL-60 - in-vitro, NA, 1-
*antiOx↑, *Inflam↓, *AntiBio↑, *cardioP↑, AntiCan↑, TumCCA↑, PI3K↓, MAPK↑, ROS↑, Apoptosis↑, Casp9↑, Bcl-2↓, p‑P53↓,
4644- HT,    The Hydroxytyrosol Induces the Death for Apoptosis of Human Melanoma Cells
- in-vitro, Melanoma, NA
tumCV↓, Apoptosis↑, P53↑, γH2AX↑, Akt↓, ROS↑, DNAdam↑,
7567- HYP,    Hyperoside: A review on its sources, biological activities, and molecular mechanisms
- Review, Var, NA
*AntiCan↑, *Bacteria↓, *AntiViral↑, *antiD↓, *RenoP↑, *hepatoP↑, *eff↑, *Sepsis↓, *AntiArt↑, *Stroke↓, TumCMig↓, TumCI↓, MTA1↓, TIMP2↓, MMP2↓, MMP↓, Cyt‑c↑, Akt↓, mTOR↓, P70S6K↓, TumAuto↑, PD-L1↓, TNF-α↓, IL1β↓, IL6↓, IL8↓, Bcl-2↓, Bcl-xL↓, BAX↑, BAD↑, Bak↑, VEGF↓, Casp3↑, Casp8↑, P53↑, GSH↓, SOD↓, Catalase↓, TAC↓, XIAP↓, ROS↓, NF-kB↓, TLR4↓, P-gp/ABCB1↓, LRP1↓, Fas↑, p27/CDKN1B↑, *cardioP↑, *AntiThr↑, *PAI-1/SERPINE1↓, *BUN↓, *ALAT↓, *AST↓, *neuroP?,
7607- I3C,    Indole-3-carbinol induces G1 cell cycle arrest and apoptosis through aryl hydrocarbon receptor in THP-1 monocytic cell line
- in-vitro, AML, THP1
AhR↑, TumCP↓, selectivity↑, Bcl-2↓, Fas↑, P21↑, p27/CDKN1B↑, P53↓, CDK2↓,
7588- I3C,    Indole-3-carbinol suppresses NF-κB activity and stimulates the p53 pathway in pre-B acute lymphoblastic leukemia cells
- in-vitro, AML, NA
TumCG↓, TumCCA↑, Apoptosis↑, P53↑, P21↑, BAX↑, PUMA↑, NOXA↑, APAF1↑, NF-kB↓, IAP1↓, Bcl-xL↓, Bcl-2↓, XIAP↓, Myc↓, ChemoSen↑, Casp9↑, cl‑PARP↑, eff↑,
7855- isoO,    Isoorientin induces apoptosis and autophagy simultaneously by reactive oxygen species (ROS)-related p53, PI3K/Akt, JNK, and p38 signaling pathways in HepG2 cancer cells
- in-vitro, Liver, HepG2 - in-vitro, Nor, HL7702
TumAuto↑, Beclin-1/ATG6↑, LC3II↑, eff↓, ROS↑, Fas↑, P53↓, PI3K↓, Akt↓, NF-kB↓, Cyt‑c↑, Casp3↑, cl‑PARP↑,
8034- IVM,  doxoR,    Synergistic potential of Ivermectin and doxorubicin in oral squamous cell carcinoma: an in vitro investigation
- in-vitro, Oral, NA
tumCV↓, selectivity↑, TumCCA↑, Apoptosis↓, BAX↑, Casp3↑, P53↑, Bcl-2↓, Ki-67↓, IL6↓, ROS↑, mtDam↑,
8029- IVM,    Ivermectin in Cancer Treatment: Should Healthcare Providers Caution or Explore Its Therapeutic Potential?
- Review, Var, NA
TumCP↓, Apoptosis↑, Wnt↓, β-catenin/ZEB1↓, Akt↓, mTOR↓, BBB∅, ROS↑, MMP↓, Casp3↓, Casp9↑, TumCCA↑, P53↑, cMyc↓, MMP9↓, HSP27↓, ICD↑, Synergy↑, *AntiP↑,
8027- IVM,    Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin
- Review, Var, NA
*AntiP↑, TumCD↑, PAK1↑, TumAuto↑, Casp↑, ICD↑, TCF↝, Hippo↓, Akt↓, mTOR↓, angioG↓, CSCs↓, MMP↓, Cyt‑c↑, Apoptosis↑, BAX↑, P53↑, Bcl-2↓, cycE/CCNE↓, cycD1/CCND1↓, CDK2↓, CDK6↓, CDK4↓, YAP/TEAD↓, TFE3↑, mTORC1↓, mitResp↓, OCR↓, compI↓, MMP↓, ROS↑, SOD2↑, ATP↓, eff↓, mitA↓, P-gp/ABCB1↓, TumVol↓,
8004- JG,    TP53 Is a Potential Target of Juglone Against Colorectal Cancer: Based on a Combination of Molecular Docking, Molecular Dynamics Simulation, and In Vitro Experiments
- in-vitro, CRC, NA
*Inflam↓, *AntiViral↑, *AntiCan↑, ROS↑, P53↑, TumCP↓,
5117- JG,    https://pubmed.ncbi.nlm.nih.gov/31283929/
- vitro+vivo, Liver, NA
TumCG↓, TumCP↓, Apoptosis↑, TumAuto↑, AMPK↑, mTOR↑, P53↑, H2O2↑, ROS↑,
1918- JG,    ROS -mediated p53 activation by juglone enhances apoptosis and autophagy in vivo and in vitro
- in-vitro, Liver, HepG2 - in-vivo, NA, NA
TumCG↓, TumCP↓, Apoptosis↑, TumAuto↑, AMPK↑, mTOR↑, P53↑, H2O2↑, ROS↑, toxicity↝, p62↓, DR5↑, Casp8↑, PARP↑, cl‑Casp3↑,
8085- KAE,    Effects and Mechanisms of Kaempferol in the Management of Cancers through Modulation of Inflammation and Signal Transduction Pathways
- Review, Var, NA
Apoptosis↑, TumCCA↑, angioG↓, PI3K↓, Akt↓, STAT3↓, AP-1↓, NRF2↓, BioAv↑, Inflam↓, NF-kB↓, TNF-α↓, VEGF↓, BAX↑, Casp↑, Bcl-2↓, P53↑, PTEN↑, hTERT/TERT↓, NRF2↓, ROS↑, DR5↑, ERK↑, CHOP/DDIT3↑, DR4↑, JNK↑, Ki-67↓, ChemoSen↑,
8087- KAE,    Therapeutic Importance of Kaempferol in the Treatment of Cancer through the Modulation of Cell Signalling Pathways
- Review, Var, NA
TumCCA↓, ROS↝, Apoptosis↑, TumCP↑, TumMeta↓, angioG↓, PI3K↓, EMT↓, Snail↓, E-cadherin↓, N-cadherin↓, MMP2↓, Casp9↑, Casp7↑, PARP↑, Apoptosis↑, *ROS↓, Hif1a↓, p‑Akt↓, P53↑, cMyc↓, Glycolysis↓, PKM2↓, miR-339-5p↝, BioAv↓,
8090- KAE,    A systematic review of anti-cancer roles and mechanisms of kaempferol as a natural compound
- Review, Nor, NA
*cardioP↑, *AntiCan↑, *Inflam↓, *neuroP↑, *BioAv↓, selectivity?, p‑Akt↓, p‑cycD1/CCND1↓, p‑CDK4↓, p‑BID↓, p‑Mcl-1↓, p‑BRCA1↑, ATM↑, P53↑, P21↑, p38↑, BAX↑, BID↑, MMP↓, Casp3↑, Casp7↑, Casp9↑, AIF↑, ER Stress↑, TumMeta↓, ERK↓, AP-1↓, JNK↓, p38↓, GLUT1↓, GlucoseCon↓, MMP9↓, CYP1A1↓, ChemoSen↑, OCT4↓, Nanog↓, P-gp/ABCB1↓, ALDH1A1↓, TumCCA↑, DNAdam↑, γH2AX↑, COX2/PTGS2↓, i-ROS↓, Ca+2↓, eff↑, DR5↑, ChemoSen↑, Akt↓, PI3K↓, ROS↑, EMT↓, survivin↓,

Showing Research Papers: 251 to 300 of 519
Prev Page 6 of 11 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 519

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 2,  

Redox & Oxidative Stress(tgid=1) ⓘ

4-HNE↑, 1,   antiOx↓, 5,   antiOx↑, 15,   antiOx⇅, 1,   ARE↑, 1,   Catalase↓, 10,   Catalase↑, 8,   Copper↑, 1,   ENOX2↓, 1,   Fenton↑, 2,   frataxin↑, 1,   GPx↓, 2,   GPx↑, 5,   GPx4↓, 8,   GSH↓, 45,   GSH↑, 12,   GSH/GSSG↓, 1,   GSR↑, 3,   GSS↑, 1,   GSSG↑, 1,   GSTs↓, 2,   GSTs↑, 2,   GSTs↝, 1,   H2O2↑, 7,   HO-1↓, 7,   HO-1↑, 17,   HO-1⇅, 1,   HO-1↝, 1,   HO-2↓, 1,   Iron↓, 3,   Iron↑, 4,   Iron↝, 1,   i-Iron↑, 1,   Keap1↓, 1,   lipid-P↓, 8,   lipid-P↑, 15,   MDA↓, 3,   MDA↑, 10,   MPO↓, 1,   NADH↓, 2,   NOX4↑, 1,   NQO1↓, 2,   NQO1↑, 3,   NRF2↓, 20,   NRF2↑, 29,   NRF2↝, 2,   PAO↑, 1,   Prx↓, 1,   PYCR1↓, 1,   RNS↑, 1,   ROS?, 2,   ROS↓, 28,   ROS↑, 267,   ROS⇅, 8,   ROS↝, 3,   ROS∅, 1,   i-ROS↓, 1,   i-ROS↑, 1,   mt-ROS↑, 5,   SOD↓, 13,   SOD↑, 13,   SOD1↓, 1,   SOD1↑, 2,   SOD2↓, 2,   SOD2↑, 2,   TAC↓, 2,   TAC↑, 1,   TBARS↓, 1,   TBARS↑, 1,   Thiols↓, 1,   Trx↓, 1,   Trx1↑, 1,   TrxR↓, 4,   TrxR1↓, 1,   xCT/SLC7A11↓, 6,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 1,   Ferritin↑, 1,   TfR1/CD71↓, 1,   TfR1/CD71↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

BCR↓, 1,   CDC16↓, 1,   CDC2↓, 7,   CDC2↑, 1,   CDC25↓, 15,   CDC25↑, 1,   CDC25↝, 1,   p‑CDC25↑, 1,   compI↓, 2,   compIII↓, 2,   compV↓, 1,   EGF↓, 5,   ETC↓, 4,   ETC↑, 1,   HSP60/HSPD1↑, 1,   Insulin↓, 1,   MFN2↑, 1,   mitResp↓, 4,   MKK7↓, 1,   mtDam↑, 23,   OCR↓, 5,   OXPHOS↓, 3,   OXPHOS↑, 4,   PDH↑, 2,   PHB↓, 1,   PHB↑, 1,   SDH↑, 1,   SIRT3↓, 2,   SIRT3↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 3,   5LO↓, 4,   ACC↑, 3,   ACSL4↑, 1,   ALAT↓, 4,   AMPK↓, 2,   AMPK↑, 28,   p‑AMPK↑, 2,   ATP↓, 14,   ATP↑, 1,   CAIX/CA9↓, 3,   CAIX/CA9↑, 1,   CholSyn↓, 1,   ECAR↓, 2,   ECAR↝, 1,   FAO↓, 1,   FAO↑, 1,   FASN↓, 10,   G6PD↓, 2,   GAPDH↓, 1,   GLO-I↓, 1,   GLS↓, 2,   GlucoseCon↓, 6,   GlutaM↓, 1,   GlutMet↓, 1,   Glycolysis↓, 27,   GSK‐3β↓, 9,   GSK‐3β↑, 6,   p‑GSK‐3β↓, 6,   H2S↑, 1,   Histones↑, 2,   HK1↓, 1,   HK2↓, 14,   HMG-CoA↓, 1,   IDH1↑, 1,   lactateProd↓, 6,   lactateProd↑, 1,   LDHA↓, 7,   LDL↓, 2,   MCT4↓, 1,   NADH:NAD↓, 1,   NADPH↓, 1,   NADPH↑, 1,   O-Glc↓, 1,   PDK1 / PDPK1?, 2,   PDK1 / PDPK1↓, 6,   PDKs↓, 1,   PFK↓, 1,   PFK1↓, 1,   PFKP↓, 1,   PKM2↓, 14,   PPP↓, 1,   p‑S6↓, 1,   SCD1↓, 1,   SIRT1↓, 7,   SIRT1↑, 10,   SREBP1/SREBF1↓, 2,   SREBP2↓, 1,   SSAT↑, 1,   TCA↓, 1,   TCA↑, 1,   TS↓, 1,   Warburg↓, 6,  

Cell Death(tgid=5) ⓘ

AIF↑, 13,   APAF1↑, 12,   Apoptosis?, 1,   Apoptosis↓, 9,   Apoptosis↑, 259,   Apoptosis↝, 1,   mt-Apoptosis↑, 4,   BAD↓, 3,   BAD↑, 12,   Bak↓, 1,   Bak↑, 13,   BAX↓, 6,   BAX↑, 199,   BAX⇅, 1,   BAX↝, 2,   BAX∅, 1,   Bax:Bcl2↑, 32,   Bcl-2↓, 196,   Bcl-2↑, 4,   Bcl-2↝, 1,   Bcl-2∅, 1,   Bcl-xL↓, 50,   Bcl-xL↑, 2,   Bcl-xL↝, 1,   Bcl-xL∅, 1,   BID↓, 2,   BID↑, 10,   p‑BID↓, 1,   BIM↓, 1,   BIM↑, 8,   BNIP3↑, 2,   BNIP3↝, 1,   BOK↑, 1,   Casp↓, 2,   Casp↑, 41,   Casp↝, 1,   cl‑Casp↑, 2,   Casp1↑, 1,   Casp10↓, 1,   Casp10↑, 2,   Casp12↑, 2,   Casp12↝, 1,   Casp2↑, 1,   Casp3↓, 5,   Casp3↑, 182,   Casp3↝, 1,   cl‑Casp3↑, 39,   cl‑Casp3⇅, 1,   proCasp3↓, 1,   proCasp3↑, 1,   CASP4↑, 1,   Casp6↑, 1,   Casp7↑, 22,   cl‑Casp7↑, 6,   Casp8↓, 1,   Casp8↑, 46,   cl‑Casp8↑, 5,   proCasp8↓, 1,   proCasp8↑, 1,   Casp9↑, 117,   p‑Casp9↑, 1,   cl‑Casp9↑, 12,   proCasp9↓, 3,   proCasp9↑, 1,   cFLIP↓, 4,   Cyt‑c↓, 3,   Cyt‑c↑, 97,   Cyt‑c↝, 3,   mt-Cyt‑c↓, 1,   Diablo↑, 9,   DIDO1/DIO-1↑, 1,   DR5↓, 1,   DR5↑, 25,   Endon↑, 1,   FADD↑, 7,   Fap1↓, 1,   Fas↓, 2,   Fas↑, 28,   FasL↑, 11,   Ferroptosis↓, 1,   Ferroptosis↑, 13,   GRP58↓, 1,   GSDME-N↑, 1,   HEY1↓, 1,   IAP1↓, 12,   IAP2/BIRC3↓, 4,   IAP2/BIRC3↑, 1,   cl‑IAP2/BIRC3↑, 1,   ICD↑, 2,   iNOS↓, 21,   iNOS↑, 2,   JWA↑, 1,   Mcl-1↓, 22,   Mcl-1↑, 1,   p‑Mcl-1↓, 1,   MDM2↓, 21,   MDM2↑, 4,   p‑MDM2↓, 1,   MLKL↑, 1,   p‑MLKL↓, 1,   MOMP↑, 2,   NAIP↓, 1,   Necroptosis↑, 3,   necrosis↑, 5,   NOXA↑, 6,   p38↓, 5,   p38↑, 22,   p‑p38↓, 3,   p‑p38↑, 3,   PUMA↑, 13,   Pyro↑, 2,   RIP3↑, 3,   p‑RIP3↑, 1,   survivin↓, 65,   TNFR 1↑, 1,   TRAIL↑, 7,   TRAIL⇅, 1,   TRAILR↑, 4,   TumCD↓, 2,   TumCD↑, 23,   TUNEL↑, 1,   XIAP↓, 33,   XIAP↑, 1,   YAP/TEAD↓, 4,   YAP/TEAD↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 131,   Akt↑, 5,   Akt↝, 1,   p‑Akt↓, 35,   p‑Akt↑, 1,   AKT1↓, 2,   Akt2↓, 2,   AMPKα↑, 2,   CaMKII ↓, 1,   CDC7↓, 1,   CK2↓, 4,   cMET↓, 3,   p‑CREB↑, 1,   cSrc↓, 1,   DDIT4↑, 1,   EF-1α↓, 1,   EGFR↓, 40,   EGFR↑, 1,   EGFR↝, 1,   p‑EGFR↓, 4,   ERK↓, 49,   ERK↑, 8,   ERK↝, 1,   p‑ERK↓, 11,   p‑ERK↑, 4,   p‑ERK⇅, 1,   p‑ERK↝, 1,   e-ERK↑, 1,   FGFR1↓, 4,   FGFR2↓, 1,   FOXD3↑, 1,   HER2/EBBR2↓, 13,   p‑HER2/EBBR2↓, 1,   HGF/c-Met↓, 1,   Hippo↓, 2,   HRAS↓, 2,   IGF-1R↓, 3,   IGFR↓, 1,   IKKα↓, 8,   IKKα↑, 1,   p‑IKKα↓, 2,   IR↓, 1,   IκB↓, 1,   IκB↑, 1,   p‑IκB↓, 1,   JAK↓, 7,   JAK1↓, 2,   p‑JAK1↓, 1,   JAK2↓, 9,   p‑JAK2↓, 3,   p‑JAK3↓, 1,   JNK↓, 6,   JNK↑, 26,   JNK↝, 1,   p‑JNK↓, 3,   MAP2K1/MEK1↓, 2,   p‑MAP2K1/MEK1↓, 1,   MAPK↓, 39,   MAPK↑, 16,   MAPK↝, 3,   p‑MAPK↓, 1,   MEK↓, 3,   p‑MEK↓, 1,   MKK4↓, 1,   mTOR↓, 67,   mTOR↑, 3,   mTOR↝, 2,   p‑mTOR↓, 9,   mTORC2↓, 1,   NIK↓, 1,   p‑p42↓, 1,   p70S6↓, 1,   p70S6↑, 1,   P70S6K↓, 2,   p‑P70S6K↓, 1,   p‑P90RSK↑, 1,   PAK↓, 1,   PDGFR-BB↓, 1,   PDGFRA↓, 1,   PI3K↓, 93,   PI3K↑, 4,   PI3K↝, 2,   p‑PI3K↓, 4,   PI3K/Akt↓, 3,   PI3k/Akt/mTOR↓, 1,   PIAS-3↑, 1,   PKA↓, 1,   PKCδ↓, 6,   PP2A↑, 1,   PTEN↓, 2,   PTEN↑, 26,   PTEN↝, 1,   Raf↓, 4,   e-Raf↓, 1,   c-Raf↓, 1,   RAS↓, 12,   RIP1↑, 2,   RTK-RAS↓, 1,   p‑S6K↓, 1,   Sp1/3/4↓, 7,   Src↓, 2,   Src↑, 1,   STAT↓, 4,   STAT3↓, 63,   STAT3↑, 1,   p‑STAT3↓, 12,   i-STAT3↓, 1,   STAT4↓, 1,   STAT5↓, 4,   STAT6↓, 1,   STK11/LKB1↑, 1,   TSC2↑, 3,   p‑TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF3↑, 3,   ATF4↓, 1,   ATF4↑, 11,   CBP↓, 1,   CBP↑, 1,   ChrMod↑, 2,   cJun↓, 6,   cJun↑, 4,   p‑cJun↑, 1,   cMyc↓, 44,   cMyc↑, 1,   p‑cMyc↑, 1,   DNMT1↓, 8,   DNMT3A↓, 2,   DNMT3B↓, 1,   DNMTs↓, 7,   EZH2↓, 1,   FOXM1↓, 2,   FOXO↑, 5,   FOXO1↓, 2,   FOXO1↑, 2,   FOXO3↓, 1,   FOXO3↑, 1,   FOXO3↝, 1,   p‑FOXO3↓, 1,   FOXO4↓, 1,   H3↓, 1,   H3↑, 2,   ac‑H3↑, 2,   H4↑, 1,   ac‑H4↑, 3,   HATs↓, 2,   HATs↑, 2,   HDAC↓, 17,   HDAC1↓, 8,   HDAC10↓, 1,   HDAC10↑, 1,   HDAC2↓, 4,   HDAC3↓, 4,   HDAC4↓, 2,   HDAC6↓, 1,   HDAC8↓, 1,   miR-107↑, 1,   miR-122-5p↑, 1,   miR-125b↓, 1,   miR-126↑, 1,   miR-133a-3p↑, 1,   miR-139-5p↑, 1,   miR-155↓, 2,   miR-195↑, 1,   miR-199↑, 1,   miR-203↓, 1,   miR-206↑, 1,   miR-21↓, 3,   miR-21↑, 2,   miR-210↓, 1,   miR-210↑, 1,   miR-218↑, 1,   miR-221↑, 1,   miR-222↑, 1,   miR-224↓, 1,   miR-326-5p↑, 1,   miR-339-5p↝, 1,   miR-340↓, 1,   miR-34a↓, 1,   miR-34a↑, 7,   miR-34b-5p↑, 1,   miR-384↑, 1,   miR-422a↑, 1,   miR-590-3p↑, 1,   Myc↓, 8,   MYCN↓, 1,   NDRG1↑, 1,   OCT4↓, 9,   other↓, 5,   other↑, 5,   other↝, 11,   PAX2↓, 1,   PhotoS↑, 1,   PRMT6↓, 1,   SOX2↓, 7,   SOX4↓, 2,   TCF-4↓, 1,   TET3↑, 1,   TFE3↑, 1,   tumCV?, 1,   tumCV↓, 65,  

Protein Folding & ER Stress(tgid=8) ⓘ

cl‑ATF6↑, 1,   CHOP/DDIT3↑, 26,   cl‑CHOP/DDIT3↑, 1,   EDEM↑, 1,   eIF2α↓, 1,   eIF2α↑, 2,   p‑eIF2α↑, 3,   ER Stress↑, 31,   GRP78/BiP↑, 10,   HSF1↓, 1,   HSP27↓, 5,   HSP27↝, 1,   HSP70/HSPA5↓, 5,   HSP70/HSPA5↑, 2,   HSP70/HSPA5↝, 1,   HSP90↓, 10,   HSP90↑, 1,   HSPs↓, 2,   HSPs↑, 1,   IRE1↑, 4,   NPL4↓, 1,   NQO2↑, 1,   PDI↑, 1,   PERK↑, 3,   Proteasome↓, 1,   SERPINH1/HSP47↓, 1,   UPR↑, 3,   XBP-1↑, 2,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG3↑, 2,   ATG5↓, 1,   ATG5↑, 7,   ATG7↑, 5,   Beclin-1/ATG6↓, 5,   Beclin-1/ATG6↑, 20,   p‑Beclin-1/ATG6↑, 1,   CTSB↓, 1,   CTSD↓, 1,   LAMP2↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 2,   LC3A↑, 1,   LC3B↑, 1,   LC3B-II↑, 2,   LC3I↓, 2,   LC3I↑, 1,   LC3II↓, 2,   LC3II↑, 16,   LC3s↑, 1,   lysoMP↑, 1,   p62↓, 7,   p62↑, 6,   SESN2↑, 3,   TumAuto↓, 1,   TumAuto↑, 49,   TumAuto↝, 2,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 9,   p‑ATM↑, 3,   ATR↑, 4,   BRCA1↓, 2,   BRCA1↑, 5,   p‑BRCA1↑, 1,   BRCA2↓, 1,   BRCA2↑, 1,   CUL4B↑, 1,   DFF45↓, 1,   DFF45↑, 1,   DNAdam↓, 4,   DNAdam↑, 79,   DNArepair↓, 2,   DNArepair↑, 1,   ERCC3↑, 1,   hTERT/TERT↓, 11,   MDMX↓, 1,   MGMT↓, 2,   MSH2↑, 1,   p16↑, 5,   P53?, 3,   P53↓, 24,   P53↑, 438,   P53⇅, 1,   P53↝, 10,   P53∅, 2,   p‑P53↓, 2,   p‑P53↑, 20,   ac‑P53↑, 1,   i-P53↓, 1,   p53 Wildtype∅, 1,   PARP↓, 6,   PARP↑, 23,   p‑PARP↑, 3,   cl‑PARP↓, 1,   cl‑PARP↑, 67,   PARP1↑, 3,   cl‑PARP1↑, 3,   PCNA↓, 36,   SIRT6↓, 1,   SIRT6↑, 1,   Telomerase↓, 14,   TOP1?, 1,   TOP1↓, 2,   TOP2↓, 3,   TRF2↓, 1,   UHRF1↓, 1,   XRCC1↓, 1,   γH2AX↓, 1,   γH2AX↑, 13,   p‑γH2AX↑, 4,  

Cell Cycle & Senescence(tgid=11) ⓘ

ANAPC2↑, 1,   AURKB↑, 1,   CC(CDKs/cyclins)↓, 1,   CC(CDKs/cyclins)↑, 1,   CDK1↓, 21,   CDK1↑, 4,   CDK1↝, 1,   CDK2↓, 46,   CDK2↑, 2,   CDK4↓, 53,   CDK4↑, 2,   p‑CDK4↓, 1,   CDK4/6↓, 2,   CDK6↓, 24,   CDK6↑, 2,   CDK8↓, 1,   CDKN2C/p18↑, 1,   CHK1↓, 4,   CHK1↑, 5,   CHK1↝, 1,   p‑CHK1↑, 2,   Chk2↓, 4,   Chk2↑, 4,   ChrCon↑, 1,   Cyc↓, 4,   Cyc↝, 1,   cycA1/CCNA1↓, 10,   cycA1/CCNA1↑, 3,   CycB/CCNB1↓, 39,   CycB/CCNB1↑, 2,   CycB/CCNB1↝, 1,   cycD1/CCND1↓, 96,   cycD1/CCND1↑, 1,   cycD1/CCND1↝, 1,   p‑cycD1/CCND1↓, 1,   CycD3↓, 3,   cycE/CCNE↓, 29,   cycE/CCNE↑, 1,   cycE/CCNE↝, 1,   cycE1↓, 1,   cycF↓, 1,   cycF↑, 1,   E2Fs↓, 6,   E2Fs↑, 1,   GADD45A↓, 1,   GADD45A↑, 3,   Ki-67↓, 29,   mitA↓, 1,   mitA↑, 3,   P21?, 2,   P21↓, 9,   P21↑, 137,   P21↝, 1,   p27/CDKN1B↓, 4,   p27/CDKN1B↑, 39,   pRB↑, 2,   p‑pRB↓, 3,   RB1↓, 1,   RB1↑, 4,   p‑RB1↓, 5,   TumCCA↓, 6,   TumCCA↑, 242,   WEE1↑, 2,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 1,   ALDH↓, 3,   ALDH1A1↓, 3,   Axin2↑, 1,   BMPs↑, 1,   CD133↓, 7,   CD133↑, 1,   CD24↓, 2,   cFos↓, 6,   CSCs?, 1,   CSCs↓, 34,   Diff↓, 1,   Diff↑, 2,   EIF4E↓, 1,   EP300↑, 1,   EP4/PTGER4↑, 1,   FGF↓, 4,   Gli1↓, 2,   HH↓, 1,   HMGCR↓, 2,   IGF-1↓, 10,   p‑IGF-1↓, 1,   IGFBP3↑, 3,   IGFBP7↑, 1,   p‑Jun↓, 1,   Ki-67↓, 29,   Let-7↑, 1,   mTORC1↓, 6,   Nanog↓, 9,   Nestin↓, 1,   NF2↑, 1,   NICD↓, 1,   NOTCH↓, 12,   NOTCH↑, 1,   NOTCH1↓, 12,   NOTCH1↝, 1,   NOTCH3↓, 2,   p300↓, 1,   PTCH1↓, 1,   SCF↓, 1,   Shh↓, 3,   Smo↓, 2,   STAT1↓, 1,   p‑STAT1↓, 1,   TAZ↓, 1,   TumCG?, 3,   TumCG↓, 76,   TumCG↑, 3,   TumCP?, 1,   TumCP↓, 151,   TumCP↑, 2,   TumCP⇅, 1,   tyrosinase↓, 1,   URGCP/URG4↓, 1,   Wnt?, 1,   Wnt↓, 31,   Wnt↝, 1,   Wnt/(β-catenin)↓, 6,   ZFX↓, 1,  

Migration(tgid=13) ⓘ

AEG1↓, 1,   AntiAg↓, 1,   AntiAg↑, 2,   AP-1↓, 10,   AP-1↝, 2,   APC↑, 1,   ATPase↓, 2,   BACH1↓, 1,   Ca+2↓, 2,   Ca+2↑, 27,   Ca+2↝, 2,   i-Ca+2?, 1,   CAFs/TAFs↓, 1,   cal2↑, 1,   CCN2/CTGF↓, 2,   Cdc42↓, 1,   COL1↓, 1,   COL3A1↓, 1,   CTNNB1↓, 1,   DLC1↑, 1,   E-cadherin↓, 6,   E-cadherin↑, 30,   EMT↓, 59,   EMT↑, 2,   EMT↝, 1,   EpCAM↓, 2,   FAK↓, 16,   p‑FAK↓, 4,   Fibronectin↓, 2,   GLI2↓, 2,   hnRNPA1↓, 1,   IQGAP3↓, 1,   ITGA5↓, 2,   ITGB1↓, 3,   ITGB3↓, 1,   ITGB4↓, 1,   ITGB6↓, 1,   KAI1/CD82↑, 1,   KRAS↓, 3,   LAMs↓, 2,   LEF1↓, 1,   LRP1↓, 1,   MALAT1↓, 1,   MET↓, 1,   MMP1↓, 4,   MMP13↓, 4,   MMP16↓, 1,   MMP2↓, 61,   MMP2↝, 1,   MMP3↓, 6,   MMP7↓, 6,   MMP9↓, 83,   MMP9↑, 1,   MMP9:TIMP1↓, 1,   MMPs↓, 33,   MTA1↓, 1,   MUC4↓, 1,   N-cadherin↓, 25,   p‑p44↓, 1,   PAK1↓, 1,   PAK1↑, 1,   pax↓, 1,   p‑pax↓, 1,   PDGF↓, 8,   proline↓, 1,   Rac1↓, 3,   RECK↑, 1,   Rho↓, 4,   ROCK1↓, 4,   Sharpin↓, 1,   Slug↓, 6,   SMAD3↓, 1,   SMAD4↑, 1,   Snail↓, 18,   TET1↓, 1,   TET1↑, 2,   TGF-β↓, 14,   THBS1↑, 1,   TIMP1↓, 1,   TIMP1↑, 9,   TIMP2↓, 2,   TIMP2↑, 9,   TIMP3↑, 1,   TPM4↓, 1,   TRIB3↑, 2,   TSC1↑, 1,   TSP-1↑, 4,   TumCA↓, 1,   TumCI↓, 56,   TumCI↑, 2,   TumCMig↓, 68,   TumCMig↑, 1,   TumMeta↓, 68,   TumMeta↑, 6,   Twist↓, 17,   uPA↓, 17,   uPAR↓, 2,   Vim↓, 31,   Zeb1↓, 8,   ZEB2↓, 1,   α-tubulin↓, 1,   β-catenin/ZEB1↓, 36,   β-catenin/ZEB1↑, 2,   β-catenin/ZEB1↝, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 70,   angioG↑, 3,   CCN1/CYR61↓, 1,   CD31/PECAM-1↓, 6,   CD31/PECAM-1↑, 1,   Endoglin↑, 1,   eNOS↓, 1,   HIF-1↓, 7,   Hif1a↓, 57,   Hif1a↑, 2,   Hif1a↝, 1,   LOX1↓, 1,   NO↓, 8,   NO↑, 3,   VCAM-1↓, 3,   VEGF↓, 87,   VEGF↝, 1,   VEGFR1↓, 1,   VEGFR2/KDR/Flk1↓, 16,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 5,   BBB∅, 1,   CellMemb↓, 1,   CellMemb↑, 2,   CLDN2↓, 1,   CTR1↑, 2,   EPR↑, 4,   GLUT1↓, 6,   GLUT1↑, 1,   GLUT3↓, 1,   GLUT3↑, 1,   GLUT4↓, 2,   KCNH2/hERG↓, 1,   MMP↓, 127,   MMP↑, 1,   MMP↝, 1,   MPT↑, 2,   NHE1↓, 2,   TRPV1↑, 4,   TRPV1↝, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

ANXA1↓, 1,   CCR7↓, 1,   CD4+↓, 1,   CD4+↑, 3,   CD44↓, 10,   CD8+↑, 4,   cDC2↓, 2,   p‑cDC2↑, 1,   COX1↓, 2,   COX2/PTGS2↓, 84,   COX2/PTGS2↝, 1,   CXCL1↓, 1,   CXCL12↓, 1,   CXCR2↓, 2,   CXCR3↓, 1,   CXCR4↓, 11,   DCells↑, 1,   DR4↑, 8,   DR6↑, 1,   FOXP3↓, 1,   HCAR1↓, 1,   HMGB1↓, 4,   ICAM-1↓, 2,   IFN-γ↓, 5,   IFN-γ↑, 2,   IL1↓, 8,   IL1↑, 1,   IL10↓, 6,   IL12↓, 4,   IL17↓, 1,   IL18↓, 1,   IL1α↓, 1,   IL1β↓, 17,   IL1β↑, 2,   IL2↓, 5,   IL2↑, 3,   IL4↓, 3,   IL4↑, 1,   IL5↓, 1,   IL6↓, 38,   IL6↝, 1,   IL8↓, 8,   Imm↑, 8,   Inflam↓, 31,   Inflam↝, 1,   M2 MC↓, 1,   MCP1/CCL2↓, 2,   MCT1↓, 3,   MDSCs↓, 1,   MyD88↑, 1,   NAF1↓, 1,   NF-kB↓, 152,   NF-kB↑, 9,   NF-kB↝, 1,   p‑NF-kB↓, 2,   p‑NF-kB↑, 1,   NK cell↑, 4,   NLRP3↓, 4,   p50↓, 1,   p65↓, 9,   p65↑, 1,   p‑p65↓, 1,   ac‑p65↓, 1,   PD-1↓, 2,   PD-1↝, 1,   PD-L1↓, 6,   PGE1↓, 1,   PGE2↓, 14,   PSA↓, 10,   PSA↝, 1,   RAGE↓, 2,   Resistin↓, 1,   SOCS-3↑, 2,   SOCS1↑, 1,   T-Cell↑, 1,   TCF↝, 1,   Th1 response↑, 1,   TLR4↓, 4,   TLR4↑, 1,   TNF-α↓, 34,   TNF-α↑, 7,   TNF-α↝, 1,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 2,   Treg lymp↓, 2,  

Cellular Microenvironment(tgid=17) ⓘ

GFAP↓, 1,   pH↓, 1,   pH↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   Ach↓, 1,   AChE↑, 1,   PTN↓, 1,  

Protein Aggregation(tgid=19) ⓘ

XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AhR↓, 1,   AhR↑, 1,   AR↓, 14,   AR↑, 1,   AR↝, 2,   ER-α36↓, 4,   ER(estro)↓, 2,   ER(estro)↑, 1,   ERα/ESR1↓, 1,   Estro↝, 1,   EstroRS/ERS↓, 1,   FGF21↓, 1,   Irisin↓, 1,   Leptin↓, 1,   PPARα↝, 1,   cl‑PPARα↓, 1,   PPARγ↓, 2,   PPARγ↑, 7,   RANKL↓, 1,   SRC3↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 1,   BioAv↓, 33,   BioAv↑, 24,   BioAv↝, 9,   chemoR↓, 1,   ChemoSen↓, 2,   ChemoSen↑, 131,   ChemoSen↝, 1,   CompStab?, 1,   CompStab↓, 2,   CompStab↑, 2,   CompStab↝, 1,   CYP1A1↓, 4,   CYP1A1↑, 3,   CYP1A2↓, 1,   CYP1A2↑, 1,   CYP1B1↑, 1,   CYP2A3/CYP2A6↓, 1,   CYP2E1↑, 1,   CYP3A4↓, 3,   Dose?, 3,   Dose↓, 1,   Dose↑, 6,   Dose⇅, 1,   Dose↝, 43,   Dose∅, 14,   eff?, 1,   eff↓, 38,   eff↑, 56,   eff↝, 10,   eff∅, 3,   GSTA1↑, 1,   Half-Life↓, 5,   Half-Life↝, 6,   MDR1↓, 5,   MRP1/ABCC1↓, 3,   P-gp/ABCB1↓, 18,   P-gp/ABCB1∅, 1,   P450↓, 4,   P450↝, 1,   RadioS↑, 39,   RadioS↝, 1,   selectivity?, 2,   selectivity↓, 2,   selectivity↑, 90,   Synergy↑, 70,   TET2↓, 1,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

AFP?, 1,   AFP↓, 2,   ALAT↓, 4,   ALP↓, 1,   AR↓, 14,   AR↑, 1,   AR↝, 2,   AST↓, 4,   BG↓, 1,   BMD↑, 1,   BRCA1↓, 2,   BRCA1↑, 5,   p‑BRCA1↑, 1,   CEA↓, 1,   creat↓, 1,   CRP↓, 3,   E6↓, 7,   E7↓, 6,   EGFR↓, 40,   EGFR↑, 1,   EGFR↝, 1,   p‑EGFR↓, 4,   ERα/ESR1↓, 1,   EstroRS/ERS↓, 1,   EZH2↓, 1,   Ferritin↓, 1,   Ferritin↑, 1,   FOXM1↓, 2,   HER2/EBBR2↓, 13,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 11,   IL6↓, 38,   IL6↝, 1,   KRAS↓, 3,   LDH↓, 6,   LDH↑, 2,   i-LDH↓, 1,   Maspin↑, 1,   Myc↓, 8,   PD-L1↓, 6,   PSA↓, 10,   PSA↝, 1,   RAGE↓, 2,   TG/TAG↓, 1,   TRIB3↑, 2,   Tumccf↓, 2,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 1,   AntiCan↓, 1,   AntiCan↑, 36,   AntiCan∅, 1,   antiCG↓, 1,   antiNeop↑, 1,   AntiTum↓, 1,   AntiTum↑, 17,   Appetite↑, 1,   BowelM↑, 2,   breath↑, 1,   cachexia↓, 1,   cardioP↑, 6,   chemoP↑, 23,   chemoPv↑, 19,   ChemoSideEff↓, 6,   fatigue↓, 1,   hepatoP↑, 10,   motorD↑, 1,   Mucositis↓, 1,   neuroP↓, 1,   neuroP↑, 3,   NP/CIPN↓, 1,   OS?, 1,   OS↑, 17,   OS⇅, 1,   OS∅, 1,   Pain↓, 2,   QoL↑, 5,   radioP↑, 7,   RenoP↑, 6,   Risk↓, 13,   Sleep↑, 2,   Strength↑, 2,   TGFβR1↑, 1,   toxicity?, 1,   toxicity↓, 9,   toxicity↑, 1,   toxicity↝, 6,   toxicity∅, 2,   TumVol↓, 23,   TumVol↑, 1,   TumW↓, 8,   Weight↑, 2,  

Infection & Microbiome(tgid=24) ⓘ

Bacteria↓, 2,   GutMicro↑, 8,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 2,   Ingr↝, 3,  
Total Targets: 1124

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1,   antiOx↓, 2,   antiOx↑, 62,   ARE↑, 1,   Bil↓, 1,   Catalase↑, 32,   GPx↑, 29,   GPx1↑, 2,   GPx4↑, 1,   GSH↑, 27,   GSR↑, 6,   GSSG↓, 1,   GSTs↑, 11,   H2O2↓, 3,   HDL↑, 2,   HO-1?, 1,   HO-1↓, 2,   HO-1↑, 14,   Keap1↓, 2,   Keap1↑, 1,   Keap1↝, 1,   lipid-P↓, 31,   MDA↓, 21,   MDA↑, 1,   MPO↓, 3,   NQO1↑, 2,   NRF2↓, 1,   NRF2↑, 34,   Prx↑, 1,   RNS↓, 3,   ROS↓, 70,   ROS↑, 4,   ROS∅, 2,   mt-ROS?, 1,   SOD↓, 1,   SOD↑, 38,   SOD1↑, 4,   SOD2↑, 5,   TAC↑, 5,   TBARS↓, 3,   uricA↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↓, 1,   IronCh↑, 2,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

DRP1/DNM1L↓, 1,   Insulin↑, 1,   MFN2↑, 1,   PGC-1α↝, 1,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

15-LOX/ALOX15↓, 1,   5LO↝, 1,   ALAT↓, 11,   AMPK↓, 1,   AMPK↑, 7,   ATP↓, 1,   ATP↑, 5,   FASN↓, 1,   glucose↓, 5,   glucose↑, 1,   glucose↝, 1,   GlucoseCon↑, 2,   Glycolysis↑, 1,   GSK‐3β↓, 3,   GSK‐3β↑, 1,   H2S↑, 1,   HK2↑, 1,   HMG-CoA↓, 1,   LDL↓, 3,   lipidLev↓, 1,   NAD↓, 1,   NAD↑, 1,   NADPH↑, 2,   SCFAs↑, 1,   SIRT1↑, 3,  

Cell Death(tgid=5) ⓘ

AIF↓, 1,   AIF↑, 1,   APAF1↓, 1,   Apoptosis↓, 3,   Apoptosis↑, 1,   ASK1↓, 1,   BAX↓, 4,   BAX↑, 1,   Bax:Bcl2↑, 2,   Bax:Bcl2↝, 1,   Bcl-2↓, 2,   Bcl-2↑, 4,   Casp↓, 1,   Casp3?, 1,   Casp3↓, 10,   Casp3↑, 1,   Casp3∅, 1,   cl‑Casp3↑, 1,   Casp8↑, 1,   cl‑Casp8↑, 1,   Casp9↓, 7,   Casp9↑, 1,   cl‑Casp9↑, 1,   Cyt‑c↓, 4,   Cyt‑c↑, 1,   Cyt‑c∅, 1,   Fas↓, 1,   Fas↑, 2,   Ferroptosis↓, 1,   GSDMD↓, 1,   iNOS↓, 13,   p38↓, 2,   survivin↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 2,   Akt↑, 3,   Akt2↓, 1,   ERK↓, 1,   ERK↑, 1,   p‑ERK↑, 1,   HGF/c-Met↑, 1,   IGF-1R↓, 1,   IKKα↓, 2,   IκB?, 1,   JAK↓, 2,   JNK↓, 4,   JNK↑, 1,   p‑JNK↓, 1,   MAPK↓, 6,   MAPK↑, 1,   mTOR↓, 1,   mTOR↑, 1,   PDGFR-BB↓, 1,   PI3K↓, 2,   PI3K↑, 2,   PKCδ↓, 1,   STAT3↓, 2,   STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 1,   ATF2↑, 1,   ATF4↓, 1,   p‑cMyc↑, 1,   FOXO3↑, 1,   HDAC2↓, 1,   other↓, 2,   other↑, 2,   other↝, 2,   tumCV↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 1,   CHOP/DDIT3↑, 1,   ER Stress↓, 1,   GRP78/BiP↑, 1,   GRP94↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 2,   Beclin-1/ATG6↑, 1,   LC3II↓, 1,   LC3II↑, 1,   MitoP↑, 1,   p62↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1,   p16↓, 1,   P53↓, 12,   P53↑, 7,   P53↝, 1,   cl‑PARP↑, 2,   PARP1↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 1,   CDK2↓, 1,   cycA1/CCNA1↓, 1,   CycB/CCNB1↓, 1,   cycD1/CCND1↓, 1,   cycE/CCNE↑, 1,   E2Fs↑, 1,   GADD34↓, 1,   P21↓, 4,   P21↑, 4,   TumCCA↑, 4,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

HH↓, 1,   TumCG↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 5,   AP-1↓, 3,   Ca+2↓, 2,   Ca+2↝, 1,   MLC2/MYL9↝, 1,   MMP13↓, 1,   MMP2↓, 1,   PAI-1/SERPINE1↓, 1,   TregCell↑, 1,   TumMeta↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↑, 1,   eNOS↑, 1,   Hif1a↓, 1,   NO↓, 8,   NO↑, 2,   VCAM-1↓, 2,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 8,   GastroP↑, 3,   GLUT2↑, 2,   GLUT3↑, 1,   GLUT4↑, 3,   H+/K+-ATPase↓, 1,   MMP↓, 3,   MMP↑, 5,   MMP∅, 1,   OCLN↝, 1,   TJ↑, 1,   TRPA1↑, 1,   TRPC1↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD4+↑, 1,   CD8+↑, 1,   COX1↓, 1,   COX2/PTGS2↓, 21,   COX2/PTGS2↑, 1,   DR4↓, 1,   ICAM-1↓, 1,   IFN-γ↓, 1,   IFN-γ↑, 1,   IL1↓, 1,   IL10↓, 2,   IL10↑, 1,   IL17↓, 1,   IL18↓, 1,   IL1β↓, 11,   IL4↓, 1,   IL5↓, 1,   IL6↓, 16,   IL6↑, 1,   IL8↓, 4,   Imm↓, 1,   Imm↑, 2,   Inflam↓, 60,   Inflam↑, 1,   pol-M2 MC↑, 1,   NeuroI↓, 1,   NF-kB?, 1,   NF-kB↓, 30,   p‑NF-kB↓, 1,   NK cell↑, 1,   NLRP3↓, 1,   PGE2↓, 6,   PSA∅, 1,   RAGE↓, 1,   SOCS-3↓, 1,   TLR4↓, 3,   TNF-α↓, 26,   β-HEX↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   5HT↑, 2,   AChE↓, 14,   BChE↓, 3,   BDNF↓, 1,   BDNF↑, 2,   EndoR↑, 1,   GABA↑, 2,   MAOA↓, 1,   monoA↑, 1,   NGF↑, 1,   β-Endo↑, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 2,   APP↓, 1,   Aβ↓, 8,   BACE/β-secretase↓, 4,   tau↓, 2,   p‑tau↓, 2,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACE/ACE1↓, 1,   ACE2↓, 1,   AHR↓, 1,   Estro↓, 1,   GPER↑, 1,   GR↑, 1,   PPARα↝, 1,   PPARγ↓, 1,   PPARγ↑, 2,   testos↑, 2,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 25,   BioAv↑, 24,   BioAv↝, 8,   BioAv∅, 1,   BioEnh↑, 1,   CompStab↑, 1,   Dose↝, 8,   Dose∅, 1,   eff↑, 7,   GSTA1↓, 1,   GSTA1↑, 1,   Half-Life↝, 5,   Half-Life∅, 2,   P450↓, 1,   Synergy↑, 7,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 11,   ALP↓, 4,   AST↓, 10,   Bil↓, 1,   BMD↑, 2,   BP↓, 3,   BP↝, 1,   BUN↓, 1,   CEA↓, 1,   creat↓, 3,   CRP↓, 4,   hs-CRP↓, 1,   IL6↓, 16,   IL6↑, 1,   IRes↝, 1,   LDH↓, 6,   NOS2↓, 2,   PSA∅, 1,   RAGE↓, 1,   TC↓, 2,   TG/TAG↓, 2,   VLDL↓, 1,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 1,   AntiAge↑, 5,   antiAll↑, 11,   AntiArt↑, 4,   AntiCan↑, 13,   antiD↓, 1,   AntiDiabetic↑, 15,   antiPs↑, 1,   AntiTum↑, 3,   Bone Healing↑, 1,   cardioP?, 1,   cardioP↑, 24,   chemoP↑, 6,   chemoPv↑, 2,   cognitive↓, 1,   cognitive↑, 8,   diuretic↑, 2,   hepatoP↓, 1,   hepatoP↑, 20,   Learn↑, 1,   memory↑, 8,   motorD↑, 2,   Mucositis↓, 1,   neuroP?, 1,   neuroP↑, 40,   Obesity↓, 7,   OS↑, 1,   Pain↓, 3,   radioP↑, 3,   RenoP↑, 5,   Risk↓, 1,   Sleep↑, 1,   Stroke↓, 5,   toxicity↓, 21,   toxicity↑, 1,   toxicity↝, 7,   toxicity∅, 2,   Wound Healing↑, 5,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 10,   AntiFungal↑, 5,   AntiP↑, 2,   AntiViral↑, 9,   Bacteria↓, 17,   Bacteria↑, 1,   Diar↓, 1,   GutMicro↑, 9,   Inf↓, 1,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↑, 1,   Ingr↝, 6,  
Total Targets: 355

Scientific Paper Hit Count for: P53, P53-Guardian of the Genome
32 Silver-NanoParticles
20 Thymoquinone
18 Curcumin
18 Quercetin
16 Apigenin (mainly Parsley)
14 Fisetin
11 Magnetic Fields
11 Resveratrol
10 Phenethyl isothiocyanate
10 EGCG (Epigallocatechin Gallate)
9 Cisplatin
9 Propolis -bee glue
9 Capsaicin
9 Emodin
9 Lycopene
8 Luteolin
8 Shikonin
7 Silymarin (Milk Thistle) silibinin
7 Allicin (mainly Garlic)
7 Ashwagandha(Withaferin A)
7 Baicalein
7 Berberine
7 Kaempferol
7 Urolithin
6 Alpha-Lipoic-Acid
6 Radiotherapy/Radiation
6 Eugenol
6 Ferulic acid
6 Gambogic Acid
6 Melatonin
5 Chlorogenic acid
5 Ursolic acid
5 Ellagic acid
5 Licorice
5 Magnolol
5 Matrine
5 Sulforaphane (mainly Broccoli)
4 Benzyl isothiocyanate
4 Bromelain
4 Chrysin
4 Selenium NanoParticles
4 Dandelion Root
4 Fenbendazole
4 Gallic acid
4 Lactoferrin/Talactoferrin
4 Nimbolide
4 Marjoram (Origanum majorana)
4 salinomycin
3 Metformin
3 Boron
3 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
3 D-limonene
3 Eurycomanone
3 Formononetin
3 Flaxseed/Linseed
3 Hibiscus sabdariffa
3 HydroxyTyrosol
3 Ivermectin
3 Juglone
3 Lemongrass Extract/Citral
3 Lutein
3 Magnetic Field Rotating
3 Aflavin-3,3′-digallate
2 Cynara scolymus/Globe Artichoke/Artichoke Extract
2 Gemcitabine (Gemzar)
2 Allyl isothiocyanate
2 Anethole/trans-Anethole
2 Isovitexin
2 Artemisinin
2 Astaxanthin
2 Berbamine
2 Betulinic acid
2 Brucea javanica
2 brusatol
2 α-Bisabolol / Chamomile oil
2 Caffeic acid
2 Carnosic acid
2 Caffeic Acid Phenethyl Ester (CAPE)
2 Carvacrol
2 Celastrol
2 Crocetin
2 Cucurbitacin
2 Docetaxel
2 Chlorella (Chlorella vulgaris)
2 Spirulina(Arthrospira/Limnospira)
2 Dichloroacetate
2 Genistein (soy isoflavone)
2 Garcinol
2 Geraniol
2 Graviola
2 Honokiol
2 Indole-3-carbinol
2 doxorubicin
2 lambertianic acid
2 Licochalcone A
2 Linalool
2 mebendazole
2 Moringin
2 Moringa oleifera
2 Mushroom Lion’s Mane, Hericium erinaceus
2 Oleuropein
2 Patchouli Oil (Pogostemon cablin)
2 Piperine
2 Piperlongumine
2 Parthenolide
2 Pterostilbene
2 Selenite (Sodium)
2 Vitamin C (Ascorbic Acid)
2 VitK3,menadione
2 Vitexin
1 1,8-Cineole
1 Astragalus
1 Anzaroot, Astragalus fasciculifolius Bioss
1 Camptothecin
1 tamoxifen
1 alpha Linolenic acid
1 DTS(dibenzyl trisulphide) from Anamu
1 Ascorbyl Palmitate
1 Trastuzumab
1 Atorvastatin
1 Aloe anthraquinones
1 epirubicin
1 Biochanin A
1 Beta-Caryophyllene
1 Isothiocyanates
1 borneol
1 Boswellia (frankincense)
1 Beetroot
1 Bruteridin(bergamot juice)
1 Mung Bean Sprouts
1 Centella asiatica / Gotu kola → asiaticoside
1 Cinnamon
1 Carvone
1 Copper and Cu NanoParticles
1 Cynaropicrin
1 Date Fruit Extract
1 diet FMD Fasting Mimicking Diet
1 Chemotherapy
1 Vitamin A, Retinoic Acid
1 Disulfiram
1 Ginkgo biloba-EGb 761
1 Tetrahydroxystilbene glucoside
1 Evodiamine
1 Exercise
1 SDG/lignans
1 Flaxseed Oil
1 Paclitaxel/Taxol
1 carboplatin
1 olaparib/LYNPARZA
1 Ginkgo biloba
1 γ-linolenic acid (Borage Oil)
1 Gold NanoParticles
1 Hydrogen Gas
1 Hydroxycinnamic-acid
1 Hyperoside
1 isoorientin
1 Mangiferin
1 Morin
1 Naringin
1 Niclosamide (Niclocide)
1 Neem
1 Oxygen, Hyperbaric
1 Phenylbutyrate
1 Propyl gallate
1 Phycocyanin
1 Plumbagin
1 Psoralidin
1 Rosmarinic acid
1 Rutin
1 buckwheat sprouts
1 Selenium
1 irinotecan
1 Sesamin
1 Lignans
1 Oxaliplatin
1 Vitamin K2
1 Wogonin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:236  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page